| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of chaperone-mediated autophagy | 6.65e-06 | 8 | 103 | 3 | GO:1904714 | |
| GeneOntologyCellularComponent | inward rectifying potassium channel | 1.49e-04 | 4 | 105 | 2 | GO:0008282 | |
| Domain | CCP | 1.02e-05 | 54 | 100 | 5 | SM00032 | |
| Domain | SUSHI | 1.22e-05 | 56 | 100 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 1.34e-05 | 57 | 100 | 5 | IPR000436 | |
| Domain | Mit_uncoupling | 3.16e-05 | 12 | 100 | 3 | IPR002030 | |
| Domain | Sushi | 1.72e-04 | 52 | 100 | 4 | PF00084 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 12906867 | ||
| Pubmed | 5.72e-07 | 22 | 106 | 4 | 35245678 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.55e-06 | 197 | 106 | 7 | 20811636 | |
| Pubmed | Nicotinamide-rich diet improves physical endurance by up-regulating SUR2A in the heart. | 9.20e-06 | 2 | 106 | 2 | 20731746 | |
| Pubmed | Amplified expression of uncoupling proteins in human brain ischemic lesions. | 9.20e-06 | 2 | 106 | 2 | 18018477 | |
| Pubmed | KATP channel subunits are expressed in the epididymal epithelium in several mammalian species. | 9.20e-06 | 2 | 106 | 2 | 18434629 | |
| Pubmed | Human pentraxin 3 binds to the complement regulator c4b-binding protein. | 9.20e-06 | 2 | 106 | 2 | 21915248 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22360462 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 9.20e-06 | 2 | 106 | 2 | 27890662 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31356773 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 9.20e-06 | 2 | 106 | 2 | 21439553 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24037327 | ||
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 9.20e-06 | 2 | 106 | 2 | 24408017 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27086859 | ||
| Pubmed | Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2A. | 9.20e-06 | 2 | 106 | 2 | 10093054 | |
| Pubmed | Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease. | 2.17e-05 | 18 | 106 | 3 | 24058526 | |
| Pubmed | 2.56e-05 | 506 | 106 | 9 | 30890647 | ||
| Pubmed | Synergistic association of mitochondrial uncoupling protein (UCP) genes with schizophrenia. | 2.76e-05 | 3 | 106 | 2 | 17066476 | |
| Pubmed | Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells. | 2.76e-05 | 3 | 106 | 2 | 12934053 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26182433 | ||
| Pubmed | Caveolin-3 negatively regulates recombinant cardiac K(ATP) channels. | 2.76e-05 | 3 | 106 | 2 | 19481058 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17167224 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21984445 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18001767 | ||
| Pubmed | Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel. | 2.76e-05 | 3 | 106 | 2 | 9130167 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11136227 | ||
| Pubmed | M-LDH serves as a sarcolemmal K(ATP) channel subunit essential for cell protection against ischemia. | 2.76e-05 | 3 | 106 | 2 | 12145195 | |
| Pubmed | Functional roles of KATP channel subunits in metabolic inhibition. | 2.76e-05 | 3 | 106 | 2 | 23624089 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19527720 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22524567 | ||
| Pubmed | Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. | 2.76e-05 | 3 | 106 | 2 | 15314180 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26683461 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 8630239 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 34289004 | ||
| Pubmed | WBP2 HDAC9 ADAMTS1 IFT172 ZNF329 LARS1 ARMCX4 EEF1A1 USP8 FRY WIZ SNRNP70 RECK ZMYM5 | 3.66e-05 | 1285 | 106 | 14 | 35914814 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 9361014 | ||
| Pubmed | Assembly limits the pharmacological complexity of ATP-sensitive potassium channels. | 5.50e-05 | 4 | 106 | 2 | 11825905 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 21378161 | ||
| Pubmed | Expression of mRNA transcripts for ATP-sensitive potassium channels in human myometrium. | 5.50e-05 | 4 | 106 | 2 | 12356945 | |
| Pubmed | Expression of ATP-sensitive K+ channel subunits during perinatal maturation in the mouse heart. | 5.50e-05 | 4 | 106 | 2 | 16085792 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 10022826 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 28842488 | ||
| Pubmed | BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1. | 5.50e-05 | 4 | 106 | 2 | 25733871 | |
| Pubmed | Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles. | 9.15e-05 | 5 | 106 | 2 | 10024132 | |
| Pubmed | Specific sequence of motifs of mitochondrial uncoupling proteins. | 9.15e-05 | 5 | 106 | 2 | 10772343 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 12900932 | ||
| Pubmed | The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. | 9.15e-05 | 5 | 106 | 2 | 10620491 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 17570749 | ||
| Pubmed | 1.37e-04 | 6 | 106 | 2 | 21035764 | ||
| Pubmed | Ankyrin-B regulates Kir6.2 membrane expression and function in heart. | 1.37e-04 | 6 | 106 | 2 | 20610380 | |
| Pubmed | 1.43e-04 | 162 | 106 | 5 | 25796446 | ||
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 21653639 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 1.91e-04 | 7 | 106 | 2 | 9004048 | |
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 19805629 | ||
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 25471572 | ||
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 24825905 | ||
| Pubmed | 2.57e-04 | 407 | 106 | 7 | 12693553 | ||
| Pubmed | 3.70e-04 | 199 | 106 | 5 | 23382691 | ||
| Pubmed | Stimulatory effect of splicing factors on transcriptional elongation. | 4.08e-04 | 10 | 106 | 2 | 11780068 | |
| Pubmed | A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site. | 4.08e-04 | 10 | 106 | 2 | 11500380 | |
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 4.86e-04 | 50 | 106 | 3 | 29560723 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CDK9 POLA1 NPEPPS LARS1 RECQL ERI1 CTSA BIRC6 EEF1A1 USP8 FH USP15 PLOD2 | 4.89e-04 | 1455 | 106 | 13 | 22863883 |
| Pubmed | 4.97e-04 | 11 | 106 | 2 | 9032278 | ||
| Pubmed | Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse. | 4.97e-04 | 11 | 106 | 2 | 15739233 | |
| Pubmed | The IFT-A complex regulates Shh signaling through cilia structure and membrane protein trafficking. | 4.97e-04 | 11 | 106 | 2 | 22689656 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 5.45e-04 | 331 | 106 | 6 | 19490893 | |
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 5.77e-04 | 53 | 106 | 3 | 23266187 | |
| Pubmed | RBM24 is a major regulator of muscle-specific alternative splicing. | 5.95e-04 | 12 | 106 | 2 | 25313962 | |
| Pubmed | Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. | 5.95e-04 | 12 | 106 | 2 | 18329369 | |
| Pubmed | 5.95e-04 | 12 | 106 | 2 | 20301549 | ||
| Pubmed | UCP2 Regulates Embryonic Neurogenesis via ROS-Mediated Yap Alternation in the Developing Neocortex. | 5.95e-04 | 12 | 106 | 2 | 28276603 | |
| Pubmed | Collagen XIV is important for growth and structural integrity of the myocardium. | 5.95e-04 | 12 | 106 | 2 | 22906538 | |
| Pubmed | Genome-wide and candidate gene association study of cigarette smoking behaviors. | 7.02e-04 | 13 | 106 | 2 | 19247474 | |
| Pubmed | Interaction network of human aminoacyl-tRNA synthetases and subunits of elongation factor 1 complex. | 7.02e-04 | 13 | 106 | 2 | 11829477 | |
| Pubmed | 7.02e-04 | 13 | 106 | 2 | 32909945 | ||
| Pubmed | Extensive gene duplications and a large inversion characterize the human leukocyte receptor cluster. | 8.18e-04 | 14 | 106 | 2 | 10941842 | |
| Pubmed | Mouse Kif7/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling. | 8.18e-04 | 14 | 106 | 2 | 19666503 | |
| Pubmed | Complex interactions between genes controlling trafficking in primary cilia. | 8.18e-04 | 14 | 106 | 2 | 21552265 | |
| Pubmed | Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening. | 8.71e-04 | 61 | 106 | 3 | 35205757 | |
| Pubmed | 8.81e-04 | 363 | 106 | 6 | 25036637 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 8.85e-04 | 139 | 106 | 4 | 16985003 | |
| Pubmed | Deubiquitinating enzymes: a new class of biological regulators. | 9.41e-04 | 15 | 106 | 2 | 9827704 | |
| Pubmed | 9.41e-04 | 15 | 106 | 2 | 8812466 | ||
| Pubmed | 9.57e-04 | 63 | 106 | 3 | 11572484 | ||
| Pubmed | 1.01e-03 | 513 | 106 | 7 | 25798074 | ||
| Pubmed | Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. | 1.05e-03 | 65 | 106 | 3 | 23319000 | |
| Pubmed | 1.07e-03 | 16 | 106 | 2 | 11013263 | ||
| Pubmed | Hedgehog signalling in the mouse requires intraflagellar transport proteins. | 1.07e-03 | 16 | 106 | 2 | 14603322 | |
| Pubmed | SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. | 1.09e-03 | 147 | 106 | 4 | 33080218 | |
| Pubmed | 1.21e-03 | 17 | 106 | 2 | 28778798 | ||
| Pubmed | 1.21e-03 | 17 | 106 | 2 | 27783955 | ||
| Pubmed | 1.25e-03 | 69 | 106 | 3 | 32238831 | ||
| Pubmed | 1.36e-03 | 18 | 106 | 2 | 14730302 | ||
| Pubmed | Does 3D Phenotyping Yield Substantial Insights in the Genetics of the Mouse Mandible Shape? | 1.36e-03 | 18 | 106 | 2 | 26921296 | |
| Pubmed | CDK9 WBP2 NPEPPS LARS1 RECQL FAM83H EEF1A1 SF3B3 FH SNRNP70 USP15 | 1.50e-03 | 1247 | 106 | 11 | 27684187 | |
| Pubmed | Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. | 1.52e-03 | 19 | 106 | 2 | 14671302 | |
| Pubmed | 1.52e-03 | 19 | 106 | 2 | 16061793 | ||
| Pubmed | Polymorphisms in mitochondrial genes and prostate cancer risk. | 1.52e-03 | 74 | 106 | 3 | 19064571 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | PDPR MAOA DSC2 ADAMTS1 ITGA1 CTSA EEF1A1 SNED1 CFD SF3B3 OXNAD1 PLOD2 | 1.57e-03 | 1451 | 106 | 12 | 30550785 |
| Pubmed | 1.65e-03 | 76 | 106 | 3 | 19336475 | ||
| Interaction | PSG8 interactions | 1.77e-06 | 41 | 100 | 5 | int:PSG8 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.80e-06 | 57 | 75 | 5 | 1179 | |
| Coexpression | ZHENG_IL22_SIGNALING_UP | 3.63e-06 | 58 | 105 | 5 | M1800 | |
| Coexpression | ZHENG_IL22_SIGNALING_UP | 1.21e-05 | 74 | 105 | 5 | MM762 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-07 | 180 | 105 | 7 | ea7a1ccf0dd3bb5af5df87501f873e7339a824b3 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.24e-07 | 196 | 105 | 7 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.86e-07 | 200 | 105 | 7 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 2.06e-06 | 158 | 105 | 6 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.65e-06 | 165 | 105 | 6 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.65e-06 | 165 | 105 | 6 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.97e-06 | 177 | 105 | 6 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-06 | 181 | 105 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.12e-06 | 185 | 105 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.44e-06 | 187 | 105 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.61e-06 | 188 | 105 | 6 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-06 | 189 | 105 | 6 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | (2)_Fibroblasts-(22)_Fibro-3|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.96e-06 | 190 | 105 | 6 | 3aed03b87ba2c8d479048c3ceef3ff5e38746c28 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 190 | 105 | 6 | 990ac07f4b0a22041daac7502f74fafd6d258cba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-06 | 190 | 105 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 190 | 105 | 6 | fc9bbe5e6e0ec3cfa47bf479d8b09a0fc53169cc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.96e-06 | 190 | 105 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 190 | 105 | 6 | 39ecdf8815e235771132684dfc1aff1917e20965 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-06 | 191 | 105 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-06 | 191 | 105 | 6 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-06 | 191 | 105 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-06 | 191 | 105 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-06 | 191 | 105 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.33e-06 | 192 | 105 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.72e-06 | 194 | 105 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 194 | 105 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.92e-06 | 195 | 105 | 6 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 195 | 105 | 6 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.92e-06 | 195 | 105 | 6 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.12e-06 | 196 | 105 | 6 | ef481eb306350311207f7a29fdfa1ae3feaba4d7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-06 | 196 | 105 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-06 | 196 | 105 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-06 | 196 | 105 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 197 | 105 | 6 | 48311c7d85ffabf59fd1685c31c18b3e84a145b5 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.33e-06 | 197 | 105 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 197 | 105 | 6 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 197 | 105 | 6 | 92f35ea602489efd29ce3a8a186d1f70d65faf40 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 197 | 105 | 6 | cd39574b5a81a361a7940c4eb26e82652addc9e9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 197 | 105 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.33e-06 | 197 | 105 | 6 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 197 | 105 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 197 | 105 | 6 | a26dd66a6bd08b46657b3a7c41669e206a8887b3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.33e-06 | 197 | 105 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.33e-06 | 197 | 105 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.33e-06 | 197 | 105 | 6 | 4946a9495ee8824540c4b45bd2a1a75696b71534 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.33e-06 | 197 | 105 | 6 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.33e-06 | 197 | 105 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | Severe_COVID-19-T/NK-CD8+_T|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.55e-06 | 198 | 105 | 6 | 584f0dc6f22bb13956a5f6950698599e382907e9 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.55e-06 | 198 | 105 | 6 | 89986c7756541df364df516329d10775ba0e78a4 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.55e-06 | 198 | 105 | 6 | 2eb80255bacddbf778b1c9eec09f74b4cdb09b36 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-06 | 198 | 105 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.55e-06 | 198 | 105 | 6 | ec99da4e269c4cd982a395cdac0e4487ab14ec39 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.55e-06 | 198 | 105 | 6 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.55e-06 | 198 | 105 | 6 | 06fdf8554148d11c0a946a7fd200edd9fa7e1965 | |
| ToppCell | COVID-19-Lymphoid-CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | 7.77e-06 | 199 | 105 | 6 | 8e322d0d097df160554e3024ec9edae4a77a66cc | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.77e-06 | 199 | 105 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.77e-06 | 199 | 105 | 6 | 9936196214a12502ebfaf152d39d40a2ed83c72d | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.77e-06 | 199 | 105 | 6 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | medial-mesenchymal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.99e-06 | 200 | 105 | 6 | 4f19e1e40966e27779bf77e8c170ed3ecc24353e | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 7.99e-06 | 200 | 105 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 1.05e-05 | 122 | 105 | 5 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 1.38e-05 | 129 | 105 | 5 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.76e-05 | 159 | 105 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 162 | 105 | 5 | bfaeff19bb56598fdc8c82be71d51787cf13928f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3-5_LINC00507_SLN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.11e-05 | 162 | 105 | 5 | b59a0081e285cdf33de56e8b523fe0e446a198f1 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 163 | 105 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-05 | 163 | 105 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.61e-05 | 166 | 105 | 5 | 62523e635784512b3261b672beaa7747cb9d114a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.75e-05 | 167 | 105 | 5 | 7cb5b52aaa5b595fe2e97d9e175294ea8d63b165 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.88e-05 | 168 | 105 | 5 | 2781dd6b369427a94c5059b44b4c8f023f5f2988 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-05 | 170 | 105 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 5.31e-05 | 171 | 105 | 5 | dfd4a15ab68ef5a9a1954b1b1540ae04017885a6 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.31e-05 | 171 | 105 | 5 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-05 | 171 | 105 | 5 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-05 | 172 | 105 | 5 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-05 | 172 | 105 | 5 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-05 | 173 | 105 | 5 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | facs-Marrow-KLS-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 173 | 105 | 5 | 8bffd512a4e561e23cc04478e2ca6fd5d3771fe4 | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.10e-06 | 198 | 102 | 8 | 7280_UP | |
| Drug | Glyburide | 4.81e-06 | 8 | 102 | 3 | DB01016 | |
| Disease | developmental and epileptic encephalopathy 33 (implicated_via_orthology) | 3.54e-05 | 3 | 102 | 2 | DOID:0080463 (implicated_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 3.27e-04 | 8 | 102 | 2 | C0266294 | |
| Disease | Experimental Autoimmune Encephalomyelitis | 4.19e-04 | 9 | 102 | 2 | C0014072 | |
| Disease | Tachycardia, Ventricular | 6.38e-04 | 11 | 102 | 2 | C0042514 | |
| Disease | health literacy measurement | 8.29e-04 | 53 | 102 | 3 | EFO_0010104 | |
| Disease | response to cisplatin, platinum measurement | 8.29e-04 | 53 | 102 | 3 | EFO_0010154, GO_0072718 | |
| Disease | peripheral arterial disease | 8.75e-04 | 54 | 102 | 3 | EFO_0004265 | |
| Disease | response to lithium ion | 9.73e-04 | 56 | 102 | 3 | GO_0010226 | |
| Disease | diabetic neuropathy (is_implicated_in) | 1.05e-03 | 14 | 102 | 2 | DOID:9743 (is_implicated_in) | |
| Disease | glucose measurement | 2.09e-03 | 380 | 102 | 6 | EFO_0004468 | |
| Disease | triacylglycerol 58:9 measurement | 2.61e-03 | 22 | 102 | 2 | EFO_0010443 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.72e-03 | 80 | 102 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | mean platelet volume | 2.81e-03 | 1020 | 102 | 10 | EFO_0004584 | |
| Disease | pulse pressure measurement | HDAC9 EPO PDPR PHF19 ABCC9 ITGA1 SRCAP FNDC1 SPATA17 KCNJ11 ABCB11 SNRNP70 | 3.11e-03 | 1392 | 102 | 12 | EFO_0005763 |
| Disease | response to peginterferon alfa-2a | 3.37e-03 | 25 | 102 | 2 | EFO_0010103 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FKTGTTLKYTCLPGY | 71 | P04003 | |
| RKSYGNFYKVPRSQT | 261 | Q8IV48 | |
| PARGKTYISTKLTRY | 51 | P16118 | |
| STNARAKIPLGFYYG | 1866 | Q9NR09 | |
| KGFKIRYAAPYCSLT | 2421 | Q96PZ7 | |
| RKGFKIRYSAPYCSL | 2456 | Q7Z408 | |
| GFGFYLYKQRTAPKT | 3646 | Q7Z407 | |
| LYKQRTAPKTQYTGC | 3651 | Q7Z407 | |
| TAYVSNEGRIRYKKP | 141 | A5X5Y0 | |
| KLGYISRVTAGKDSY | 666 | Q96Q42 | |
| GIKITGTYFKPSLYE | 1256 | Q96Q42 | |
| YSTVPKIAFYAGLKR | 121 | Q5VWW1 | |
| SNGTLPDKYKYIQTL | 451 | Q9UDR5 | |
| LGRAFSYTPSYAKAK | 1031 | O95342 | |
| YLNKSFVLGSYGPKK | 401 | Q9NU02 | |
| TFGSPFNKQRYKAVT | 771 | O60706 | |
| LILTPYGYTKNKSSN | 241 | Q8IVL8 | |
| YDPETRSSSGIRYKK | 496 | Q02487 | |
| DKQAFKYYPSTRGLT | 101 | P0CG01 | |
| AKAKKSSESRGIYPY | 1966 | Q5H9R4 | |
| GKTLKYALTFGVRQY | 746 | Q9Y2Q0 | |
| KDTTYTKIFVGGLPY | 6 | Q9BX46 | |
| KGLGYVRYLKPSQAA | 161 | Q8IUH3 | |
| TLYQRGKSLSYKGPC | 736 | O95980 | |
| LTVGNALRPKIKYTY | 826 | Q9UHI8 | |
| NRKKPGIYTRVASYA | 231 | P00746 | |
| RLVQYVKGKTYPFRG | 96 | P21397 | |
| FYGTASLTYLRPKSN | 251 | Q8NGE5 | |
| SGVDYYPKSRVLKFS | 3086 | Q86XX4 | |
| QYRLKAKYAAATGGP | 926 | P10071 | |
| SGPSIKDKYVTALYF | 606 | Q9NS40 | |
| QVIRKSYLEYKGSSP | 1071 | Q6ZRQ5 | |
| ERGSTKYSYKSPQLS | 121 | P20138 | |
| ARLQKYSTKPGSYIF | 271 | Q13191 | |
| YSVDYSKFGNTVKVP | 326 | Q14654 | |
| LYFYSGQPSQKKLVR | 396 | A8MYZ0 | |
| GYRFQAKAKLYPVAS | 846 | Q8NCN5 | |
| RSLGATLKYSYKEVG | 316 | Q9ULS6 | |
| AKPKKATQFVYSYGR | 166 | Q12986 | |
| ATQFVYSYGRGPKVK | 171 | Q12986 | |
| PRSNYGVVEKLLKTY | 556 | Q6ZU52 | |
| RTYKPEIKKGSYNNI | 2156 | P24043 | |
| MKGFYRSKYTTPSGE | 156 | A6NEC2 | |
| TKKNEPLASYLGYTV | 426 | P56199 | |
| GYPKLFQASRVKGYR | 106 | Q96RP7 | |
| KYYLVRSSQGVLSKG | 216 | Q9C091 | |
| RFYAKPLAALVTYKG | 966 | P09884 | |
| APVTLKVFAGYYTKG | 631 | O00469 | |
| IYKNKFELTYVGPSQ | 321 | Q9UG01 | |
| PLGKSKDYINASYIR | 201 | Q4JDL3 | |
| KRNGYEIGTIKLFYS | 201 | Q96HP4 | |
| GYGSCLFLYVKPKQT | 251 | Q8NGU1 | |
| LAKQPSFRQYSGYLK | 41 | P10619 | |
| GAPPIRDKSSKYYVS | 226 | Q9BYG0 | |
| KNAKFYPVTREGSYG | 126 | P54851 | |
| SYGTIKIGTYQSLKR | 81 | Q5SVS4 | |
| TVLVYTSFGYKNKVP | 151 | Q9HB03 | |
| KVPNDKYYGAQTVRS | 61 | P07954 | |
| GRKRFVAPYVTYLNK | 1606 | Q4ZHG4 | |
| TYIKKIGYNPDTVAF | 176 | P68104 | |
| VYSNFLRGKLKLYTG | 171 | P01588 | |
| TYIKKIGYNPDTVAF | 176 | Q5VTE0 | |
| RYYSGEKKAPVLTLF | 66 | Q9UK59 | |
| YSKKVAEQRPGSILY | 1291 | Q5TBA9 | |
| SPSYKYTLPGAQDAK | 196 | Q9UKV0 | |
| VGYTTLNREPAYKKH | 146 | P15882 | |
| VAGPTYYCRTGKSFK | 211 | Q6ZRV2 | |
| RTKASPYNRCKGSIY | 86 | P50750 | |
| GKTTQLPKYLYEAGF | 81 | Q8IX18 | |
| MKGFYRSKYTTPSGE | 156 | P55786 | |
| AKYKDSYNVFRLGPS | 66 | Q6ISS4 | |
| KTILFSYGTKRNPYE | 221 | P26022 | |
| RKTYFISSPKYGEGL | 306 | Q3ZCT8 | |
| FTYLKPRKSYSLGRD | 256 | Q8NGG4 | |
| YSKRSGKPRGYAFIE | 136 | P08621 | |
| YVKTYLLPDRSSQGK | 346 | Q4VX76 | |
| SSKYGPISYKEQFRS | 311 | Q96L03 | |
| IKFGKRYTIYSPKDG | 231 | Q9P2J5 | |
| GFYLSYKVRGNKPSC | 1066 | Q9Y2G9 | |
| AYRSYIQGGRPFTKK | 1451 | O95785 | |
| PSFKILTYYGAQKER | 691 | Q6ZRS2 | |
| SQPTVIRGITYYKAK | 291 | Q68BL8 | |
| GYGSCLFLYVKPKQT | 251 | Q8NGU2 | |
| TKSRYVPNGKLASYT | 1146 | Q8TER0 | |
| KGVSPSNYEKLEYRN | 321 | P54922 | |
| SKAGYRVPRSYPKSN | 191 | O95471 | |
| FTAYATISYLKIGPK | 561 | P46063 | |
| SYGTIKIGIYQSLKR | 116 | O95258 | |
| NDGYKFSNPKITVIY | 1021 | Q8N2E2 | |
| IKYPKDRGYQDASTK | 351 | Q6XR72 | |
| FYLTRVSGVKPKYNS | 166 | Q9NUW8 | |
| RIGLYDSVKQFYTKG | 96 | P55851 | |
| PKQNIFYFLYGKTRS | 121 | Q495Y7 | |
| TQKPYYGEVIKKSFS | 596 | Q8IV35 | |
| SGKFSYVTPRAFKTQ | 351 | Q9Y4E8 | |
| TDGLYYLGKIKRVSS | 51 | Q5T6S3 | |
| EIKIGPFANTTKYAY | 2116 | Q9P273 | |
| EYSSKGLLTRVYSKG | 2206 | Q9P273 | |
| NPRSVAGGFVYTYKL | 916 | Q15393 | |
| SRAVGFIQAKGYPTY | 311 | O15195 | |
| PGTKFYISYLVKKGT | 111 | O00526 | |
| PKDNTGRKFSETYYT | 551 | Q9UJ78 | |
| SLKIVAYVKYNGSRP | 451 | Q9UL62 | |
| ALPSYPKSYADKRTG | 106 | Q86UD4 | |
| QYRYISPKDFKITIG | 841 | P40818 | |
| VYKYATDKRGSLSGI | 826 | Q6ZT98 | |
| SPRDAQYLYLKGTKS | 181 | A2RUC4 | |
| LVLGKAYSYSASPQR | 471 | Q9GZU3 | |
| AFKGTKKGTVYLTPY | 41 | Q969T9 | |
| LYTEGIYRKSGSTNK | 2091 | B2RTY4 | |
| YKNGQEIRPSTKYIF | 286 | Q00872 |